These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38036805)

  • 1. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Victoria Zhang Y; Garg U
    Methods Mol Biol; 2024; 2737():1-13. PubMed ID: 38036805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography-Tandem Mass Spectrometry: An Emerging Technology in the Toxicology Laboratory.
    Zhang YV; Wei B; Zhu Y; Zhang Y; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):635-661. PubMed ID: 27842783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Urine Drug Screen by Gas Chromatography-Mass Spectrometry (GC-MS).
    Ramoo B; Clinton Frazee C; Garg U
    Methods Mol Biol; 2024; 2737():249-256. PubMed ID: 38036826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to Mass Spectrometry for Bimolecular Analysis in a Clinical Laboratory.
    Zhang YV; Garg U
    Methods Mol Biol; 2022; 2546():1-12. PubMed ID: 36127573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry in Clinical Laboratory: Applications in Biomolecular Analysis.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1378():1-9. PubMed ID: 26602111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES.
    Borden SA; Palaty J; Termopoli V; Famiglini G; Cappiello A; Gill CG; Palma P
    Mass Spectrom Rev; 2020 Sep; 39(5-6):703-744. PubMed ID: 32048319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Marquet P
    Ther Drug Monit; 2002 Apr; 24(2):255-76. PubMed ID: 11897972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The art of measuring steroids: Principles and practice of current hormonal steroid analysis.
    Wudy SA; Schuler G; Sánchez-Guijo A; Hartmann MF
    J Steroid Biochem Mol Biol; 2018 May; 179():88-103. PubMed ID: 28962971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement.
    Ma Y; Wang D; Li H; Ma X; Zou Y; Mu D; Yu S; Cheng X; Qiu L
    Clin Chim Acta; 2024 Aug; 562():119846. PubMed ID: 38969085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.
    Seger C
    Wien Med Wochenschr; 2012 Nov; 162(21-22):499-504. PubMed ID: 23129542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology.
    Maurer HH
    Ther Drug Monit; 2018 Aug; 40(4):389-393. PubMed ID: 29750739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography tandem mass spectrometry in the clinical laboratory.
    Adaway JE; Keevil BG; Owen LJ
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):18-38. PubMed ID: 25313226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview.
    Peters FT; Wissenbach D
    Expert Opin Drug Metab Toxicol; 2023; 19(8):487-500. PubMed ID: 37615282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Urine Drug Screen by Gas Chromatography/Mass Spectrometry (GC/MS).
    Ramoo B; Funke M; Frazee C; Garg U
    Methods Mol Biol; 2016; 1383():125-31. PubMed ID: 26660182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.